Summit Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Sell
1,384
-2
-0.1% -$2.03K 0.18% 63
2025
Q4
$1.49M Buy
1,386
+2
+0.1% +$1.91K 0.21% 57
2025
Q3
$1.06M Sell
1,384
-10
-0.7% -$7.44K 0.16% 68
2025
Q2
$1.09M Sell
1,394
-14
-1% -$10.9K 0.18% 66
2025
Q1
$1.16M Buy
1,408
+90
+7% +$74.9K 0.2% 61
2024
Q4
$1.02M Sell
1,318
-10
-0.8% -$8.28K 0.18% 66
2024
Q3
$1.18M Hold
1,328
0.22% 57
2024
Q2
$1.2M Hold
1,328
0.25% 47
2024
Q1
$1.03M Sell
1,328
-29
-2% -$20.6K 0.22% 51
2023
Q4
$791K Sell
1,357
-42
-3% -$24.5K 0.19% 59
2023
Q3
$751K Sell
1,399
-20
-1% -$10.3K 0.2% 56
2023
Q2
$665K Sell
1,419
-42
-3% -$17.6K 0.18% 65
2023
Q1
$502K Hold
1,461
0.14% 80
2022
Q4
$534K Sell
1,461
-147
-9% -$52.1K 0.15% 77
2022
Q3
$520K Buy
1,608
+150
+10% +$47.5K 0.17% 76
2022
Q2
$473K Buy
1,458
+15
+1% +$4.5K 0.15% 85
2022
Q1
$413K Sell
1,443
-45
-3% -$11.6K 0.12% 103
2021
Q4
$411K Buy
1,488
+62
+4% +$15.7K 0.12% 102
2021
Q3
$329K Buy
1,426
+300
+27% +$74K 0.1% 111
2021
Q2
$258K Hold
1,126
0.08% 130
2021
Q1
$210K Buy
+1,126
New +$220K 0.07% 139
2020
Q4
Sell
-1,363
Closed -$202K 136
2020
Q3
$202K Buy
+1,363
New +$211K 0.08% 126

Other funds holding LLY

Summit Asset Management's LLY Position: Q1 2026 in Review

Summit Asset Management reduced its Eli Lilly (LLY) stake by 0.14% in Q1 2026, selling an estimated $2.03K and leaving 1,384 shares worth $1.27M. The position accounts for 0.18% of the portfolio, ranked #63.

Summit Asset Management first reported a position in LLY in Q3 2020 and has held it in 22 quarters since. The position peaked at $1.49M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Summit Asset Management held 1,384 shares of Eli Lilly worth $1.27M as of Q1 2026.
  • Summit Asset Management sold 2 Eli Lilly shares in Q1 2026, an estimated $2.03K.
  • Eli Lilly made up 0.18% of Summit Asset Management's portfolio in Q1 2026, its #63 holding.
  • Summit Asset Management first reported a position in Eli Lilly in Q3 2020 and has held it in 22 quarters since.
  • Summit Asset Management's Eli Lilly position peaked at $1.49M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Summit Asset Management's 13F filing for Q1 2026, filed 8 May 2026.